100 related articles for article (PubMed ID: 8390962)
1. Analysis of ras point mutations and human papillomavirus 16 and 18 in cervical carcinomata and their metastases.
Willis G; Jennings B; Ball RY; New NE; Gibson I
Gynecol Oncol; 1993 Jun; 49(3):359-64. PubMed ID: 8390962
[TBL] [Abstract][Full Text] [Related]
2. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
[TBL] [Abstract][Full Text] [Related]
3. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
4. Lack of synergistic association between human papillomavirus and ras gene point mutation in laryngeal carcinomas.
Shidara K; Suzuki T; Hara F; Nakajima T
Laryngoscope; 1994 Aug; 104(8 Pt 1):1008-12. PubMed ID: 8052064
[TBL] [Abstract][Full Text] [Related]
5. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
Ferguson AW; Svoboda-Newman SM; Frank TS
Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417
[TBL] [Abstract][Full Text] [Related]
6. Detection of human papillomavirus types 16 and 18 in primary and in metastatic lesions of cervical carcinomas.
Mvula M; Iwasaka T; Matsuo N; Nakao Y; Kaku T; Hachisuga T; Fukuda K; Tsukamoto N; Sugimori H
Gynecol Oncol; 1994 May; 53(2):156-60. PubMed ID: 8188074
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus detection in paraffin-embedded cervical carcinomas and metastases of the carcinomas by the polymerase chain reaction.
Claas EC; Melchers WJ; van der Linden HC; Lindeman J; Quint WG
Am J Pathol; 1989 Oct; 135(4):703-9. PubMed ID: 2552814
[TBL] [Abstract][Full Text] [Related]
8. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines.
Iwasaka T; Oh-uchida M; Matsuo N; Yokoyama M; Fukuda K; Hara K; Fukuyama K; Hori K; Sugimori H
Gynecol Oncol; 1993 Jan; 48(1):104-9. PubMed ID: 8380785
[TBL] [Abstract][Full Text] [Related]
9. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas.
Anwar K; Nakakuki K; Shiraishi T; Naiki H; Yatani R; Inuzuka M
Cancer Res; 1992 Nov; 52(21):5991-6. PubMed ID: 1382850
[TBL] [Abstract][Full Text] [Related]
10. Expression and mutation of H-ras in uterine cervical cancer.
Lee JH; Lee SK; Yang MH; Ahmed MM; Mohiuddin M; Lee EY
Gynecol Oncol; 1996 Jul; 62(1):49-54. PubMed ID: 8690291
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus and mutated H-ras oncogene in cervical carcinomas and pathological negative pelvic lymph nodes: a retrospective follow-up.
Landro ME; Dalbert D; Picconi MA; Cúneo N; González J; Vornetti S; Bazán G; Mural J; Basiletti J; Teyssié AR; Alonio LV
J Med Virol; 2008 Apr; 80(4):694-701. PubMed ID: 18297710
[TBL] [Abstract][Full Text] [Related]
12. Identification of H, K, and N-ras point mutations in stage IB cervical carcinoma.
Grendys EC; Barnes WA; Weitzel J; Sparkowski J; Schlegel R
Gynecol Oncol; 1997 May; 65(2):343-7. PubMed ID: 9159349
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
[TBL] [Abstract][Full Text] [Related]
14. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
[TBL] [Abstract][Full Text] [Related]
15. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
16. A c-rasHa mutation in the metastasis of a human papillomavirus (HPV)-18 positive penile squamous cell carcinoma suggests a cooperative effect between HPV-18 and c-rasHa activation in malignant progression.
Leis PF; Stevens KR; Baer SC; Kadmon D; Goldberg LH; Wang XJ
Cancer; 1998 Jul; 83(1):122-9. PubMed ID: 9655301
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus DNA in distant metastases of cervical cancer.
Ikenberg H; Teufel G; Schmitt B; Kommoss F; Stanimirovic B; Pfleiderer A
Gynecol Oncol; 1993 Jan; 48(1):56-60. PubMed ID: 8380788
[TBL] [Abstract][Full Text] [Related]
18. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.
Nakagawa S; Yoshikawa H; Jimbo H; Onda T; Yasugi T; Matsumoto K; Kino N; Kawana K; Kozuka T; Nakagawa K; Aoki M; Taketani Y
Br J Cancer; 1999 Mar; 79(7-8):1139-44. PubMed ID: 10098748
[TBL] [Abstract][Full Text] [Related]
19. Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma.
Duggan BD; Felix JC; Muderspach LI; Tsao JL; Shibata DK
Cancer Res; 1994 Mar; 54(6):1604-7. PubMed ID: 8137266
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between human papillomavirus DNA in the lymph nodes and metastasis of early-stage cervical carcinoma].
Sun Y; Liu GB; Yu YH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):796-8. PubMed ID: 18504207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]